Skip to main content

Why Novavax Stock Is Losing Ground

Shares of coronavirus vaccine developer Novavax, Inc. (NVAX) were moving sharply to the downside on above-average volume Monday. Novavax shares lost 17.65% Monday, closing at $195.12.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.